Indication

Clostridium pelvic cellulitis

*Clostridium* pelvic cellulitis refers to a serious, invasive soft-tissue infection of the female pelvis and parametrial spaces caused by susceptible species of the anaerobic bacterium *Clostridium*. Read more about Clostridium pelvic cellulitis

23 drugs 20 manufacturers

Advertisement

Drugs that treat it

Common Clostridium pelvic cellulitis therapies.

Showing 19–23 of 23 drugs

Filter & compare in the drug finder →Opens the drug finder with Clostridium pelvic cellulitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Clostridium pelvic cellulitis.

*Clostridium* pelvic cellulitis refers to a serious, invasive soft-tissue infection of the female pelvis and parametrial spaces caused by susceptible species of the anaerobic bacterium *Clostridium*.

Typically arising as a postpartum, postabortal, or postoperative gynecologic complication, this condition involves the contiguous spread of bacteria through compromised mucosal barriers into the deeper extraperitoneal connective tissue of the pelvis.

Pathophysiologically, clostridial organisms proliferate in ischemic, low-oxygen environments and release potent exotoxins and tissue-degrading enzymes, leading to marked tissue edema, microvascular thrombosis, gas production, and intense local inflammation.

Clinically, affected individuals present with lower abdominal or pelvic pain, purulent discharge, high fevers, and tender pelvic induration, with the potential to rapidly progress to pelvic abscess formation, extensive tissue necrosis, or systemic toxicity.

Personalize your experience

Follow Clostridium pelvic cellulitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it